Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.40%)
As of: Sep 4, 2026 · 3:59 PM EDT

Valneva SE (VALN) Debt Ratio (2020 - 2026)

Valneva SE (VALN) posted Debt Ratio of 0.49 for Q1 2026, up 9.11% sequentially from 0.45 in Q4 2025, and up 30.45% YoY from 0.38 in Q1 2025.

Analysis

Valneva SE (VALN) Debt Ratio (2020 - 2026) Analysis & Trends

Valneva SE has reported Debt Ratio for 7 years, with the latest figure at 0.49 in Q1 2026.

  • Quarterly Debt Ratio rose 30.45% year-over-year to 0.49 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.49 (up 30.45% YoY) and the FY2025 annual result came in at 0.45, up 19.88% from the prior year.
  • Debt Ratio rose to 0.49 in Q1 2026 per VALN's latest filing, from 0.45 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.49 in Q1 2026 and troughed at 0.08 in Q1 2022.
  • A 5-year average of 0.29 and a median of 0.36 in 2025 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2023 and 2025: Debt Ratio surged 141.73% in 2023, then slipped 7.86% in 2025.
  • Over 5 years, Debt Ratio stood at 0.16 in 2022, then soared by 141.73% to 0.38 in 2023, then slipped by 2.52% to 0.37 in 2024, then climbed by 19.88% to 0.45 in 2025, then advanced by 9.11% to 0.49 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.49, 0.45, and 0.37 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.05
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.05
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.12
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.47
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.26
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 0.90
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.90
Mar 31, 2026 0.49
Dec 31, 2025 0.85
Sep 30, 2025 0.37
Jun 30, 2025 0.36
Mar 31, 2025 0.38
Dec 31, 2024 0.37
Sep 30, 2024 0.33
Jun 30, 2024 0.73
Mar 31, 2024 0.36
Dec 31, 2023 0.38
Sep 30, 2023 0.27
Jun 30, 2023 0.18
Mar 31, 2023 0.19
Dec 31, 2022 0.18
Sep 30, 2022 0.17
Jun 30, 2022 0.12
Mar 31, 2022 0.09
Dec 31, 2021 0.08
Dec 31, 2020 0.13